Unite Us Receives Grant to Combat Ohio's Opioid Crisis and Expand Recovery Services in Montgomery County
Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by Substance Use Disorder
Dayton, Ohio--(Newsfile Corp. - February 27, 2025) - Unite Us, the nation's leading technology partner for social care transformation, has been awarded a grant from the OneOhio Recovery Foundation to strengthen opioid abatement efforts in Montgomery County. This grant will enhance the Unite Ohio network, a statewide coordinated care network, to provide critical recovery services for residents of Ohio affected by opioid addiction.
Through a powerful partnership with CliniSync, Montgomery County Alcohol, Drug Addiction, and Mental Health Services (ADAMHS) and Unite Us, this initiative will use Unite Us' care coordination platform and data and analytics tools, to improve data sharing and connect healthcare providers, local government agencies, and community-based organizations (CBOs) to deliver timely, effective support to those in need. The technology will help ensure that individuals battling addiction receive the right care at the right time, streamlining recovery pathways.
'At Unite Us, we are dedicated to ensuring individuals facing addiction can access the care and support they need, when they need it,' said Taylor Justice, co-founder and president of Unite Us. 'This grant enables us to strengthen collaboration across healthcare and community organizations in Montgomery County, leveraging technology to remove barriers to recovery. By integrating our platform with CliniSync's Health Information Exchange, we can enhance data sharing, streamline care coordination, and improve outcomes for individuals and families impacted by the opioid crisis.'
A Proven Model for Success
The growth of Unite Ohio builds on a successful opioid reduction model launched in Summit County. Led by County Executive Ilene Shapiro in 2023, this initiative leveraged Opioid Use Disorder (OUD) settlement funds and has since become a statewide blueprint for technology-driven collaboration in addiction recovery.
The success of Unite Ohio has been greatly supported by key partners like CliniSync, MetroHealth, Cleveland Clinic, and Summit County. Their early adoption of Unite Us' technology has played a crucial role in establishing coordinated care solutions across the state. Their leadership continues to influence Ohio's comprehensive strategy for addressing the opioid crisis.
A Statewide Commitment to Recovery
This grant is part of the OneOhio Recovery Foundation's $51 million inaugural funding cycle, which supports statewide initiatives in prevention, treatment, and recovery. With funding requests far exceeding available resources, this partnership with Unite Us underscores the urgent need for scalable, tech-driven solutions to combat the opioid crisis.
'Across Ohio, organizations like Unite Us are working tirelessly to strengthen communities impacted by the opioid epidemic,' said Alisha Nelson, executive director of the OneOhio Recovery Foundation. 'We're pleased to partner with Unite Us to support their efforts to save lives, rebuild families affected by addiction, and foster strong and resilient places to live.'
For more details on the grant recipients and future funding opportunities, visit OneOhioFoundation.com/GrantAwards.
About Unite Us:
Unite Us is the nation's premier technology provider for transforming social care. Our advanced product suite is used to proactively coordinate services using data-driven insights, streamline referral and case management, and facilitate eligibility assessments and reimbursements across government, healthcare, health plans, and community organizations. The first of its kind, our closed-loop referral system prioritizes privacy and dignity and has integrated data and analytics tools used to measure impact, optimize programs, and shape policy. With over 1.5M services, we host the nation's largest network of community-based health and social services dedicated to improving whole-person health. Learn more at UniteUs.com and LinkedIn.
Media Contact:
About the OneOhio Recovery Foundation
The OneOhio Recovery Foundation is a private, non-profit foundation created under the leadership of Governor Mike DeWine and Attorney General Dave Yost, and other state and local leaders, with the mission of advancing Ohio's addiction prevention, treatment, and recovery efforts now and into the future.
The Foundation is governed by a 29-member board from across Ohio and is funded by 55 percent of settlement funds that Ohio is receiving from the pharmaceutical industry as a consequence of its role in the national opioid epidemic. Funds support local efforts to prevent and combat addiction and are also invested to support those efforts for the long term.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Foundation for Opioid Response Efforts Announces New Funding Opportunity for Community-Based Organizations Addressing Opioid Use Disorder
New York, June 02, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) is announcing a new Request for Proposals (RFP) to support community-based organizations (CBOs) working to reduce opioid use disorder (OUD) and overdose mortality in local communities. FORE will hold an informational webinar on June 5, 2025, at 2:00 p.m. ET to discuss the RFP and answer questions. Interested organizations can . This RFP expands FORE's Community-Driven Responses to OUD and Overdose Mortality Program, providing new funding to help CBOs: Enhance operational effectiveness, including administration, finance, human resources, and technology, to strengthen long-term sustainability and diversify funding. Improve communications to raise awareness and attract attention and resources. Strengthen and evaluate programming to expand access to evidence-based OUD services for individuals and families. Foster cross-sector collaborations with partners in education, business, courts, and healthcare to deepen community engagement and expand services. FORE invites eligible organizations to apply for up to $75,000 per year for two years (up to $150,000 total). Applicants must be a U.S.-based 501(c)(3) or have a 501(c)(3) fiscal sponsor, have been in operation for at least two years, and have an annual operating budget between $150,000 and $7 million. Complete details and application instructions are available on FORE's Grants & Funding page. Applications must be submitted through FORE's grants management system by 11:59 p.m. PT on July 2, 2025. 'Community-based organizations are uniquely positioned to identify and respond to local needs, yet they often face barriers to securing the flexible funding they need to strengthen operations and sustain programming,' said Dr. Karen Scott, President of FORE. 'By supporting their capacity, we help ensure communities have access to effective prevention, treatment, harm reduction, and recovery services tailored to their needs.' Since 2023, FORE has supported 22 community-based organizations through capacity-building grants and remains committed to advancing community-driven, evidence-based solutions to the opioid crisis. About FOREFounded in 2018, FORE is a national 501(c)(3) grant-making foundation dedicated to addressing the nation's opioid crisis. Through strategic grantmaking, convening stakeholders, and developing informational resources, FORE supports patient-centered, innovative solutions that drive long-term change. To date, FORE has awarded 118 grants totaling $47.5 million to 101 organizations. Follow us on X (Twitter) and LinkedIn for updates. CONTACT: Myrna Manners Foundation for Opioid Response Efforts 718-986-7255 mmanners@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 hours ago
- Yahoo
Berkshire Biomedical Awarded NIH Research Grant to Support Clinical Study Program to Evaluate Patient Retention and Other Benefits of the COPA™ System for Take-Home Methadone Medication Management
Funds from the Two-Phase Fast-Track SBIR Grant, Combined, Would Total Approximately $2.9 Million DALLAS, June 2, 2025 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, today announced that it has been awarded the first phase of a two-phase Fast-Track Small Business Innovation Research (SBIR) grant (1 R44DA061908-01A1) from the National Institutes of Health's (NIH) National Institute of Drug Abuse (NIDA). Valued at approximately $2.9 million over 30 months, the two-phase grant will support execution of a clinical study to evaluate patient retention and other benefits of the Company's COPA™ System for Take-Home Methadone Medication Management as part of Medication for Opioid User Disorder (MOUD) treatment. Phase I funds of approximately $326,400 will support the execution of a single-site study. Receipt of the approximate $2.55 million Phase II award will support the execution of an open-label, randomized, parallel multi-site study, which will be contingent on an assessment of the Phase I report, as well as the review and approval of any other documentation necessary for continuation and availability of NIH funds. COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only an Authenticated Intended User (AIU™), upon confirmation of dual biometric identifications (fingerprint and dentition) prior to each dose, with the goal of enhancing patient wellness and providing remote monitoring. "The Fast-Track SBIR grant process is highly competitive, with only 18% of applicants having been chosen under this program in 2023, alone," stated John Timberlake, Chief Executive Officer of Berkshire. This is Berkshire's second Fast-Track SBIR Grant from NIH. The Company received an initial two-phased award totaling $2.2 million (1R44DA057185) in 2022 which extended through 2024, to complete the development of the COPA system. Berkshire's receipt of this newest award reflects the NIH's continued belief in the strength of the technology behind COPA and its potential to significantly increase access to Opioid Treatment Programs for persons suffering from Opioid Use Disorder (OUD) by dramatically increasing the number of persons being allowed to utilize take home therapy." Mr. Timberlake continued, "The requirement to travel to an Opioid Treatment Program (OTP) clinic, daily, has been shown to reduce treatment retention and deter some patients from even starting treatment. A mixed methods study found that take-home dose flexibility among stable patients was associated with receiving more take homes, higher rates of treatment retention, and lower rates of opioid-positive drug tests. Higher retention rates in opioid use disorder medication among patients with OUD were, therefore, associated with better outcomes. There have been a considerable number of retrospective studies evaluating opioid use disorder treatment retention; however, there are very few prospective comparison studies." About the National Institute on Drug Abuse (NIDA)NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. For more information about NIDA and its programs, visit About the National Institutes of Health (NIH)NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit About Berkshire Biomedical Corporation Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with encrypted HIPAA compliant cloud-based and healthcare provider-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU). The Company's lead product under development, the Computerized Oral Prescription Administration System (COPA), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the AIU upon confirmation of dual biometric identification (fingerprint and dentition). Upon receiving regulatory authorization, the Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of oral liquid medication methadone, for Medication Use for Opioid Use Disorder treatment and subsequently for the delivery of controlled medications for the treatment of pain, as those patients have the greatest need for the benefits of COPA's features. In addition, the Company will look to expand COPA use in broader drug therapeutic categories, clinical applications, and businesses that manage the commercialization and data analytics provided by electronic devices to improve outcomes and reduce risk. Additional information about Berkshire Biomedical and the COPA System can be found at The COPA™ System is currently under development, has NOT been reviewed by the U.S. Food and Drug Administration and is not available for commercial sale. Disclaimer: Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Numbers R44DA057185 and R44DA061908-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CONTACT: Berkshire Biomedical Corporationinfo@ Melody CareyFounder, President, and CEORx Communications Group, LLCmcarey@ View original content: SOURCE Berkshire Biomedical Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Ohio bills further regulating SNAP use, fraud prevention, see activity as cuts loom
A 'SNAP welcomed here' sign is seen at the entrance to a Big Lots store in Portland, Oregon. (Getty Images) As Ohio food assistance recipients await decisions on the federal and state level about whether they will see large cuts to their benefits, some state legislators are trying to iron out other details related to the Supplemental Nutrition Assistance Program (SNAP). Congressional budget reconciliation is ongoing in the U.S. Senate, after what anti-hunger advocates say would be a nearly 30% reduction in SNAP benefits was approved by the U.S. House in their draft of budget documents, encouraged by the Trump administration as part of efforts to slash federal spending. Advocates say the cuts will be devastating for low-income families across the country, with rural communities disproportionately impacted, according to the national Food Research & Action Center. The Ohio Association of Foodbanks said the loss of SNAP funding would restrict services 'vital for everyday Ohioans in every Congressional district.' The potential cuts come as legislators work on the state's SNAP program, with bills ranging from supplements to the benefits for older Ohioans to a push to prevent the defrauding of Ohioans who need the funds. Most recently, supporters of House Bill 163 – which would make the electronic benefit cards (EBTs) that hold SNAP benefits chip-enabled, like most mainstream credit and debit cards – spoke on the impacts chip technology would offer to households. The modernization of the EBT cards would help stem fraud through 'skimming,' a method of stealing information from the swipe of a card and capture of PIN numbers at checkouts. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX The Ohio Poverty Law Center said fraud occurs for many individuals 'in the first few days after benefits were loaded, leaving them without benefits until the next month.' Joree Novotny, executive director of the Ohio Association of Foodbanks said there was a congressional 'pathway' for state agencies to reimburse victims of benefit theft, which took nearly $17 million in SNAP benefits from more than 34,000 Ohio households between June 2023 and Dec. 2024. But the pathway ended in December of last year, when Congress decided against extending authorization for replacement of those benefits, Novotny told the Ohio House Agriculture Committee during a recent hearing on H.B. 163. Since then, it's unclear how much has been stolen from Ohioans and other SNAP beneficiaries, because Novotny said 'theft reports are no longer being collected.' Still, she said emergency food distribution representatives say the 'issue remains pervasive.' One of the sponsors of H.B. 163, state Rep. Tristan Rader, D-Lakewood, is working with fellow Democratic Rep. Desiree Tims to create a state program to replace stolen SNAP benefits in a bill that would appropriate $17 million from the state's General Revenue Fund for the task. State-level budget discussions have included maintaining work requirements for SNAP participants, along with other regulations related to waivers for SNAP participants. The state budget approved by the House also included a requirement that the Ohio Department of Job and Family Services seek a waiver from the U.S. Department of Agriculture to exclude 'sugar-sweetened beverages' from items that can be purchased using SNAP benefits. While the provision of the budget doesn't specify types of sugar-sweetened beverages, a bill introduced recently by Republican co-sponsors singles out soft drinks as an item they want to see removed from the SNAP-eligible list of products, along with candy, chips, ice cream and 'prepared desserts such as cakes, pies, cookies or similar products.' If the bill passes, those products would join alcoholic beverages, tobacco, hot foods or 'hot food products prepared for immediate consumption' as SNAP-exempted items. Last week, the sponsors of the bill said exempting 'junk food' from SNAP eligibility is one way of ensuring to taxpayers that their money is being spent for the betterment of Ohioans. 'What this bill's all about is helping focus folks who are using taxpayer money – which we're glad to provide for folks that are having a rough time, don't have resources at home, whatever the case may be – but just helping them realize there are better choices here than the stuff that adds calories … and no nutritional benefits,' Sen. Tim Schaffer, R-Lancaster, told the Senate Health Committee. Bill co-sponsor, Sen. Terry Johnson, R-McDermott, pointed to a change 'demographically in our country' toward obesity and health problems, 'and it's primarily the nutritional things that we consume.' 'We're doing America a great disservice by ignoring the fact that what people actually need is clean air, clean water, clean food, good exercise and a little bit of sunshine,' Johnson said. Committee member Sen. Beth Liston, D-Dublin, wondered whether discouraging sweets and soda consumption should start with a different population for which taxpayers subsidize food assistance, like the military or public universities. 'If you're looking at how to make the best impacts, I think looking at only poor individuals that are struggling to get by may not be, certainly not the largest population,' Liston said to the bill sponsors. 'There are many other tax-funded foods that we purchase, and if you're going to be looking at it holistically, just the SNAP program is a pretty small population.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
